1. Antitumor effect of soluble β-glucan as an immune stimulant
- Author
-
Xiaonan Zhang, Shan Liu, Chenyang Zhao, Lijuan Wu, and Zhao Jun
- Subjects
beta-Glucans ,medicine.drug_class ,medicine.medical_treatment ,02 engineering and technology ,Pharmacology ,Polysaccharide ,Biochemistry ,Immunostimulant ,03 medical and health sciences ,Immune system ,Adjuvants, Immunologic ,Structural Biology ,Neoplasms ,medicine ,Animals ,Humans ,Receptor ,Molecular Biology ,030304 developmental biology ,Glucan ,chemistry.chemical_classification ,0303 health sciences ,Innate immune system ,Cancer ,General Medicine ,021001 nanoscience & nanotechnology ,medicine.disease ,Stimulant ,chemistry ,0210 nano-technology - Abstract
β-glucans are linear polysaccharides of d-glucose monomers linked through β-glycosidic bonds and are widely present in nature. Different sources lead to their structural differences. β-glucan has long been acknowledged to be a safe and functional component. Its biological activities include lipid-lowering, hypoglycemic, antitumor and immune regulation etc. A large number of studies have shown that soluble β-glucan can bind to their receptors on the surface of immune cells, activates the pro-inflammatory response of innate immune cells, and enhances the host's antitumor defense. A variety of soluble β-glucans have been widely used in clinical antitumor studies as an immunostimulant to treat the cancer patient. In this paper, we reviewed the molecular structure, antitumor immune activities, structure-activity relationship and clinical trials of soluble β-glucans in order to provide the overall scene of β-glucans as immunostimulant to fight the cancer.
- Published
- 2021
- Full Text
- View/download PDF